1. Home
  2. CARE vs CRVS Comparison

CARE vs CRVS Comparison

Compare CARE & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter Bankshares Inc.

CARE

Carter Bankshares Inc.

HOLD

Current Price

$29.21

Market Cap

723.5M

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

SELL

Current Price

$9.97

Market Cap

843.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CARE
CRVS
Founded
1974
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.5M
843.7M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
CARE
CRVS
Price
$29.21
$9.97
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
★ $34.25
$31.50
AVG Volume (30 Days)
149.0K
★ 1.0M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 1.40%
N/A
EPS Growth
30.19
★ 48.04
EPS
★ 5.18
N/A
Revenue
★ $20,315,000.00
N/A
Revenue This Year
$76.15
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.50
★ N/A
Revenue Growth
★ 4.65
N/A
52 Week Low
$16.86
$6.39
52 Week High
$36.06
$26.95

Technical Indicators

Market Signals
Indicator
CARE
CRVS
Relative Strength Index (RSI) 30.99 38.28
Support Level $26.52 $9.21
Resistance Level $31.02 $10.81
Average True Range (ATR) 0.69 0.56
MACD -0.15 0.08
Stochastic Oscillator 4.56 32.53

Price Performance

Historical Comparison
CARE
CRVS

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: